36
Blood transfusion in anemic patients (DOSE, ADMINISTRATION OF BLOOD AND COMPONENT THERAPY) By:Dr. Yasmeen Ahmed Dr. Ajay Srivastava M.V.Sc. Scholar, Indian Veterinary Research Institute

BLOOD TRANSFUSION IN ANEMIC PATIENTS(DOSE, ADMINISTRATION, ROUTE, COMPONENT THERAPY)

Embed Size (px)

Citation preview

Page 1: BLOOD TRANSFUSION IN ANEMIC PATIENTS(DOSE, ADMINISTRATION, ROUTE, COMPONENT THERAPY)

Blood transfusion in anemic patients

(DOSE, ADMINISTRATION OF BLOOD AND COMPONENT

THERAPY)

By:Dr. Yasmeen AhmedDr. Ajay Srivastava

M.V.Sc. Scholar, Indian Veterinary Research Institute

Page 2: BLOOD TRANSFUSION IN ANEMIC PATIENTS(DOSE, ADMINISTRATION, ROUTE, COMPONENT THERAPY)

DOSE /QUANTITY OF BLOOD

• Quantity of blood to be transfused depends upon:

• Degree of anemia

• Acute hemorrhage-there will be loss of blood volume results in hypotension but no drop in PCV –PLASMA or DEXTRAN is good enough.

• Chronic Anaemia-decision of transfusion based on bone marrow response and on PCV

Page 3: BLOOD TRANSFUSION IN ANEMIC PATIENTS(DOSE, ADMINISTRATION, ROUTE, COMPONENT THERAPY)

CALCULATION OF DOSE• Calculated on the percentage of haemoglobin present and percentage

to which it should be elevated( minimum 75% of normal level

• Animal contains about 90ml of blood/kg of body weight:

ml of blood need to raise Hb to 1% = 90 x bw (kg)/100

ml of blood deficit = wt(kg) of recipient x 90 x [PCV desired – PCV recipient] / PCV of donor

Page 4: BLOOD TRANSFUSION IN ANEMIC PATIENTS(DOSE, ADMINISTRATION, ROUTE, COMPONENT THERAPY)

ADMINISTRATION OF BLOOD

Page 5: BLOOD TRANSFUSION IN ANEMIC PATIENTS(DOSE, ADMINISTRATION, ROUTE, COMPONENT THERAPY)

PRACTICAL CONSIDERATIONS WHILE BLOOD ADMINISTRATION

Total replacement of lost blood not necessary

Attaining a PCV of 25% is a REASONABLE GOAL.

Approx. 2.2ml of whole blood/ kg BW: increase PCV by 1%.

Blood transfusion should be viewed as temporary therapeutic measure.

Reference: vety. Med. By Radostits, Gay, Blood, Hinchcliff. 10th edition, Page no. 405

Page 6: BLOOD TRANSFUSION IN ANEMIC PATIENTS(DOSE, ADMINISTRATION, ROUTE, COMPONENT THERAPY)

ROUTES OF BLOOD TRANSFUSION

INTRAPERITONEAL ROUTE INTRAVENOUS ROUTE INTRAOSSEOUS ROUTE SUBCUTANEOUS ROUTE

Page 7: BLOOD TRANSFUSION IN ANEMIC PATIENTS(DOSE, ADMINISTRATION, ROUTE, COMPONENT THERAPY)

INTRAPERITONEAL ROUTE

50% of transfused blood enters the circulation within 24 hrs Max. conc. of transfused cells in circulation 2-3 days after injection Satisfactory in case of Piglets Indicated in Shocked & Uncooperative animals RATE OF TRANSFUSION THROUGH I.P. ROUTE-100 drops/min.

Page 8: BLOOD TRANSFUSION IN ANEMIC PATIENTS(DOSE, ADMINISTRATION, ROUTE, COMPONENT THERAPY)

MERITS OF I.P. ROUTE

Valuable in replacement of erythrocytes Treatment of Hemolytic Anemia in lambs

DEMERITS OF I.P. ROUTE Not satisfactory for treatment of Hypovolemic Shock Absorption of RBCs slow Not recommended in Ascites, Peritonitis, Abdominal distention, Peritoneal adhesion

Page 9: BLOOD TRANSFUSION IN ANEMIC PATIENTS(DOSE, ADMINISTRATION, ROUTE, COMPONENT THERAPY)

2. INTRAVENOUS ROUTE Best method in large % of cases Slow I.V. drip usually most desirable method and is stopped immediately if urticaria develops.

Jugular vein is preferred in ruminants

Dogs- Cephalic or Recurrent tarsal vein RATE OF TRANSFUSION THROUGH I.V. ROUTEHORSE- 10-20 ml/ kg/ hr CATTLE- 4.5 l/ hr DOG- 8-10 ml/ kg/ hr

Page 10: BLOOD TRANSFUSION IN ANEMIC PATIENTS(DOSE, ADMINISTRATION, ROUTE, COMPONENT THERAPY)

In dogs, sod. Citrate causes overloading and heart failure so administer blood very slowly or use heparin as anticoagulant.

Heparin mixed blood- safely transfused at faster rate either IV or IP.

Page 11: BLOOD TRANSFUSION IN ANEMIC PATIENTS(DOSE, ADMINISTRATION, ROUTE, COMPONENT THERAPY)

MERITS OF I.V. ROUTE

Satisfactory in treatment of Hypovolemic Shock. Therapeutic effects of transfusion delivered by I.V. injection are extremely rapid Suitable method when large volume of blood is transfused Useful in Emergency Cases

Page 12: BLOOD TRANSFUSION IN ANEMIC PATIENTS(DOSE, ADMINISTRATION, ROUTE, COMPONENT THERAPY)

DEMERITS OF I.V. ROUTE

Administration at too rapid rate a) Overloading of circulation b) Acute Heart Failure

Other complications a) Heart rate increases rapidly

b)Dyspnoea precedes collapse

Page 13: BLOOD TRANSFUSION IN ANEMIC PATIENTS(DOSE, ADMINISTRATION, ROUTE, COMPONENT THERAPY)

3. Limited application in Kittens & Small Dogs 95% of RBCs transfused into Medullary Cavity being absorbed intact Maximal uptake in 5 minutes Mainly given in long bones like femur

INTRAOSSEOUS ROUTE

Page 14: BLOOD TRANSFUSION IN ANEMIC PATIENTS(DOSE, ADMINISTRATION, ROUTE, COMPONENT THERAPY)

MERITS OF I.O. ROUTE Provides rapid access to central compartment of

circulatory system Demonstrates efficacy & onset of action.

DEMERITS OF I.O. ROUTE Contraindicated for placement of Bone marrow

needle- Skeletal abnormality, Skin & Wound infection, Abscess & Fracture

Contraindicated in Septic Shock

Page 15: BLOOD TRANSFUSION IN ANEMIC PATIENTS(DOSE, ADMINISTRATION, ROUTE, COMPONENT THERAPY)

SUBCUTANEOUS ROUTE Less frequently used Less than 3% of RBCs are absorbed, 97% are destroyed

Page 16: BLOOD TRANSFUSION IN ANEMIC PATIENTS(DOSE, ADMINISTRATION, ROUTE, COMPONENT THERAPY)

RATE OF TRANSFUSION The recommended administration rate varies (08-10ml/kg

BW/hr) but never exceed 22ml/kg/day in dogs & cats. Patients with cardiac insufficiency may not be able to

tolerate >5ml/kg/day.

A drop in PCV 36% to 12% (500kg animal) represent loss of 27 lit of blood. In this case 8lit. Of blood is req. to transfuse.

0.1ml/kg given over 5-10 min. & evaluate the vital parameters, if parameters & attitude are unchanged, the transfusion can be continued @ not exceed 20ml/kg/hr.

Reference: Manual of Small Animal Internal Medicine, 2nd edition by Nelson & Couto, page no. 773

Reference: Large Animal Internal Medicine by Bradford P. Smith 4th edition, page no. 1145

ELSEVIER MOSBY PUBLICATION

Page 17: BLOOD TRANSFUSION IN ANEMIC PATIENTS(DOSE, ADMINISTRATION, ROUTE, COMPONENT THERAPY)

4.5lit blood/hr to administer to a cow and comparable rate in small species.

In adult horse 10-20ml/kg/hr & with faster rate with rates in foal (40ml/kg/hr).

Reference: vety. Med. By Radostits, Gay, Blood, Hinchcliff. 10th edition, Page no. 406

Page 18: BLOOD TRANSFUSION IN ANEMIC PATIENTS(DOSE, ADMINISTRATION, ROUTE, COMPONENT THERAPY)

Component therapy • Definition: Whole blood is often centrifuged & processed

into blood components, such as packed RBC, plasma, platelets & cryoprecipitate, by using multiple, sterile connected plastic bags.

• Advantages: - better conservation of blood resources- longer storage of components- more specific therapy- fewer complications from circulatory overload

because of minimum volume administered

Page 19: BLOOD TRANSFUSION IN ANEMIC PATIENTS(DOSE, ADMINISTRATION, ROUTE, COMPONENT THERAPY)
Page 20: BLOOD TRANSFUSION IN ANEMIC PATIENTS(DOSE, ADMINISTRATION, ROUTE, COMPONENT THERAPY)
Page 21: BLOOD TRANSFUSION IN ANEMIC PATIENTS(DOSE, ADMINISTRATION, ROUTE, COMPONENT THERAPY)

RED BLOOD CELL PRODUCTS Only indication- clinically symptomatic Anemia

Patients asymptomatic for anemia- No transfusion unless exact Hb conc./ Hematocrit level known

Should be transfused immediately when level of Hb is one third of the normal Hb level or normal heamatocrit value.

Page 22: BLOOD TRANSFUSION IN ANEMIC PATIENTS(DOSE, ADMINISTRATION, ROUTE, COMPONENT THERAPY)

WHOLE BLOOD (WB) BLOOD COLLECTED FROM DONOR PLUS ANTICOAGULANT

MOST COMMON IN VETY. PRACTICE SINCE IT CAN BE PRODUCED WITHOUT ANY EXPENSIVE EQUIPMENT.

TYPICALLY USED TO TRANSFUSE CATS, RARELY DOGSIN CATS- 40-50 ml BLOOD + 5-9 ml ANTICOAGULANTINDICATIONS: Pediatric transfusions (SMALL PUPS)

Exchange transfusions Hypovolemic anemia from hemorrhage

CONTRAINDICATED: IN NORMOVOLEMIC ANEMIA, because of risk of volume overload from additional plasma volume adds to transfusion.

DOSE: 10-20 ml/kg b.wt

Page 23: BLOOD TRANSFUSION IN ANEMIC PATIENTS(DOSE, ADMINISTRATION, ROUTE, COMPONENT THERAPY)

PACKED RBCs (pRBCs) Cells & a small amount of plasma after plasma/ anticoagulant removal PCV= 80% (VERY VISCOUS) 0.9% NSS added to decrease viscosity & improve flow INDICATIONS: Clinically symptomatic anemia DOSAGE- 6-10 ml/kg

Page 24: BLOOD TRANSFUSION IN ANEMIC PATIENTS(DOSE, ADMINISTRATION, ROUTE, COMPONENT THERAPY)

pRBCs IN ADDITIVE SOLUTION

100 ml ADDITIVE SOLUTION ADDED TO SEPARATED RBCs

PCV= 55-60%

Additive Solutions: DEXTROSE MANNITOL SODIUM CHLORIDE ADENINE

DOSE- 10-15 ml/kg

Page 25: BLOOD TRANSFUSION IN ANEMIC PATIENTS(DOSE, ADMINISTRATION, ROUTE, COMPONENT THERAPY)

LEUKOCYTE REDUCED pRBCs

99.9% WBCs REMOVED

WBCs removed as cause certain TRANSFUSION REACTIONS- Non-hemolytic fever, immunosuppression

DOSE- 15 ml/kg

Page 26: BLOOD TRANSFUSION IN ANEMIC PATIENTS(DOSE, ADMINISTRATION, ROUTE, COMPONENT THERAPY)

PLASMA COMPONENTS

FRESH FROZEN PLASMA (FFP) Plasma from WB & RBCs removed within 6 hrs of collection

Anticoagulants remains in plasma fraction during processing.

WHEN FROZEN AT (-20 degree celsius), CLOTTING FACTORS MAINTAIN ACTIVITY FOR 1 yr at this temp.

EXCELLENT SOURCE OF CLOTTING FACTORS

Page 27: BLOOD TRANSFUSION IN ANEMIC PATIENTS(DOSE, ADMINISTRATION, ROUTE, COMPONENT THERAPY)

Indications: HEMOPHILIA von WILEBRAND’S DISEASE RODENTICIDE INTOXICATION

DOSAGE= 6-10 ml/kg sid-tid

Page 28: BLOOD TRANSFUSION IN ANEMIC PATIENTS(DOSE, ADMINISTRATION, ROUTE, COMPONENT THERAPY)

FROZEN PLASMA (FP)

PLASMA NOT PROCESSED & FROZEN WITHIN 6 hrs OF COLLECTION or FFP STORED AT -20 deg celsius FOR > 1 yr

EXCELLENT SORCE OF ALBUMIN Indications: FAILURE OF PASSIVE

TRANSFER DOSAGE- 6-10 ml/kg sid-tid

Page 29: BLOOD TRANSFUSION IN ANEMIC PATIENTS(DOSE, ADMINISTRATION, ROUTE, COMPONENT THERAPY)

CRYOPRECIPITATE

During thawing of FFP at 4 deg. Celsius, a WHITE PPT. forms in plasma & separated by centrifugation.

Excellent source of vWf, FACTOR 1(fibrinogen), factor 8

Page 30: BLOOD TRANSFUSION IN ANEMIC PATIENTS(DOSE, ADMINISTRATION, ROUTE, COMPONENT THERAPY)

Indications: von WILLEBRAND’S DISEASE

HEMOPHILIA- A FIBRINOGEN DEF.

Stored at -20 deg. Celsius for 1 yr DOSAGE- 1 unit/10 kg BW

Page 31: BLOOD TRANSFUSION IN ANEMIC PATIENTS(DOSE, ADMINISTRATION, ROUTE, COMPONENT THERAPY)

CRYO-POOR PLASMA

Plasma remaining after cryoppt. Removed

Excellent source of FACTOR 2, 7, 9, 10

Indication: RODENTICIDE INTOXICATION

DOSAGE- 1 unit/10 kg BW

Page 32: BLOOD TRANSFUSION IN ANEMIC PATIENTS(DOSE, ADMINISTRATION, ROUTE, COMPONENT THERAPY)

PLATELET- RICH PLASMA (PRP)

Prepared from fresh WB by centrifugation at a slower centrifuge rate than for production of pRBC/ plasma

PLATELETS SUSPENDED IN PLASMA TO FACILITATE TRANSFUSION & TRANSFUSED WITHIN HOURS OF COLLECTION

Indication: THROMBOCYTOPAENIA

DOSAGE- 1 unit/10 kg BW

Page 33: BLOOD TRANSFUSION IN ANEMIC PATIENTS(DOSE, ADMINISTRATION, ROUTE, COMPONENT THERAPY)

TRANSFUSION REACTION BY COMPONENTS OF BLOOD

PRODUCT CONTENT USES DOSAGE REACTION

Whole blood

RBCs, WBCs, Plasma, Platelets, Anticoagulant

Hypovolemic-ane,feline transfusion,pediatric trans,

10-20ml/kg Fever,acute hemolytic anemia, vol overload

Packed RBCs

RBCs Clinic-symptomtic anemia

6-10ml/kg Fever,acute hemolysis

Fresh frozen plasma

Plasma,anticoagulant,clottingfactor,Igs

Coagulation factor defic,passive transfer failure,von wilebrand’s

6-10ml/kg Vol overload,allergy,fever

Page 34: BLOOD TRANSFUSION IN ANEMIC PATIENTS(DOSE, ADMINISTRATION, ROUTE, COMPONENT THERAPY)

Frozen Frozen plasmaplasma

Plasma,anticoagulant,low level of clotting factors,Igs

Failure of passive transfer,

6-10ml/kg Vol overload,allergy,fever

Cryoprecipitate

Factors-VIII,XIII,Fibrinogen

Deficiency of these VonWillebrand’sdis,Hemophilia-A

1unit/10kg Allergy,fever

Cryo-poor plasma

Factors-II,IV,IX,X

Rodenticide-intoxication

6-10ml/kg -do-

Platelet-richplasma

Platelets,plasma

Decreased platelet production

1unit/10kg -do-

Frozen platelets 1*10*11platelets DMSO,Plasma

undefined 1unit/10kg b.wt bradycardia

Page 35: BLOOD TRANSFUSION IN ANEMIC PATIENTS(DOSE, ADMINISTRATION, ROUTE, COMPONENT THERAPY)

REFERENCES1.TEXTBOOK of Veterinary Internal Medicine, 6th EDITION- STEPHEN J. ETTINGER

2.VETERINARY MEDICINE- A TEXTBOOK OF DISEASE OF CATTLE, SHEEP, PIG, GOAT AND HORSES- OTTO M. RADOSTITS, CLIVE C. GRAY, DOUGLAS C. BLOOD, KENNETH W. HINCHCLIFF

3.VETERINARY HEMATOLOGY AND CLINICAL CHEMISTRY- MARY ANNAL THRALL, DALE C, BAKER, E DUAVE

4.LAB MANUAL OF CLINICAL VETERINARY MEDICINE -2

Page 36: BLOOD TRANSFUSION IN ANEMIC PATIENTS(DOSE, ADMINISTRATION, ROUTE, COMPONENT THERAPY)